Tuesday, June 21, 2022 10:02:07 PM
1. They need cannabis plant extract i.e leaves (not flower) to produce final product.
2. Cannabis plant contains all 103 cannabinoids in acid form that act as phyto-nutrients.
3. Most cannabis companies disregard them and concentrate on THC or CBD only.
4. TXTM technology retains all cannabinoids with low psychoactive part 0.1% THC.
5. By retaining all cannabinoids the drug is more potent than any other technology.
6. Due to its non-psychoactive nature drug can be sold anywhere in the world.
7. Clinical trials have been conducted and license has been issued in South Africa.
8. Drug can be sold in USA as Schedule 4 drug.
9. Final product is a capsule (powdered form) can be easy to deliver to patients.
10. No other company is able to achieve it thus far.
11. Company is ready to commercialize this in South Africa and globally.
Stay tuned for more info on tomorrow's CC and company website as well.
Links -
Former CEO Roger Duffield speaking about their technology
Links
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM